Skip to content
20-F

Annual Report (Foreign)

RedHill Biopharma Ltd. RDHL

0001104659-26-049055

← back to feed
Filed
Apr 27, 2026 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 31, 2025 50.92B sh